Different desensitization patterns for sensory and vascular TRPV1 populations in the rat: Expression, localization and functional consequences

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Czikora, Ágnes ^a   Rutkai, Ibolya ^a   Pásztor, Eniko T ^a   Szalai, Andrea ^a   Pórszász, Róbert ^a   Boczán, Judit ^a   Édes, István ^a,b   Papp, Zoltán ^a,b   Tóth, Attila ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; VANILLOID RECEPTOR 1; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; EVOKED SOMATOSENSORY RESPONSE; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; SENSORY NERVE CELL; SMOOTH MUSCLE FIBER; SPINAL GANGLION; VASOCONSTRICTION; VASODILATATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; RAT; SKELETAL MUSCLE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOLES; CAPSAICIN; GANGLIA, SPINAL; MALE; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; SENSORY RECEPTOR CELLS; TRPV CATION CHANNELS;

EID: 84892631363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078184     Document Type: Article

References (42)

1. Jancso-Gabor A, Szolcsanyi J, Jancso N (1970) Stimulation and desensitization of the hypothalamic heat-sensitive structures by capsaicin in rats. J Physiol 208: 449-459.
2. Jancso-Gabor A, Szolcsanyi J, Jancso N (1970) Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in rats and guinea-pigs. J Physiol 206: 495-507.
3. Jancso N, Jancso-Gabor A, Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 31: 138-151.
4. Jancso N, Jancso-Gabor A, Szolcsanyi J (1968) The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br J Pharmacol Chemother 33: 32-41.
5. Szolcsanyi J (1977) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 73: 251-259.
6. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, et al. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
7. Wong GY, Gavva NR (2009) Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Res Rev 60: 267-277.
8. Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, et al. (2008) Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136: 202-210.
9. Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P Jr, et al. (2008) NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 7: 1106-1112.
10. Noto C, Pappagallo M, Szallasi A (2009) NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Investig Drugs 10: 702-710.
11. Docherty RJ, Yeats JC, Bevan S, Boddeke HW (1996) Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Archiv European journal of physiology 431: 828-837.
12. Lizanecz E, Bagi Z, Pásztor ET, Papp Z, Edes I, et al. (2006) Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. Molecular pharmacology 69: 1015-1023.
13. Mohapatra DP, Nau C (2005) Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. The Journal of Biological Chemistry 280: 13424-13432.
14. Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, et al. (2003) Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci U S A 100: 12480-12485.
15. Mandadi S, Numazaki M, Tominaga M, Bhat MB, Armati PJ, et al. (2004) Activation of protein kinase C reverses capsaicin-induced calcium-dependent desensitization of TRPV1 ion channels. Cell Calcium 35: 471-478.
16. Numazaki M, Tominaga T, Toyooka H, Tominaga M (2002) Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 277: 13375-13378.
17. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, et al. (2002) cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 35: 721-731.
18. Mohapatra DP, Nau C (2003) Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. The Journal of Biological Chemistry 278: 50080-50090.
19. Ralevic V, Karoon P, Burnstock G (1995) Long-term sensory denervation by neonatal capsaicin treatment augments sympathetic neurotransmission in rat mesenteric arteries by increasing levels of norepinephrine and selectively enhancing postjunctional actions. J Pharmacol Exp Ther 274: 64-71.
20. Scadding JW (1980) The permanent anatomical effects of neonatal capsaicin on somatosensory nerves. J Anat 131: 471-482.
21. Cortright DN, Szallasi A (2004) Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 271: 1814-1819.
22. Szolcsanyi J (1983) Tetrodotoxin-resistant non-cholinergic neurogenic contraction evoked by capsaicinoids and piperine on the guinea-pig trachea. Neurosci Lett 42: 83-88.
23. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457.
24. Alawi K, Keeble J (2010) The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacology & Therapeutics 125: 181-195.
25. Fernandes ES, Fernandes MA, Keeble JE (2012) The functions of TRPA1 and TRPV1: moving away from sensory nerves. British Journal of Pharmacology 166: 510-521.
26. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, et al. (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Molecular Brain Research 135: 162-168.
27. Kark T, Bagi Z, Lizanecz E, Pásztor ET, Erdei N, et al. (2008) Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1. Molecular Pharmacology 73: 1405-1412.
28. Cavanaugh DJ, Chesler AT, Jackson AC, Sigal YM, Yamanaka H, et al. (2011) Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 31: 5067-5077.
29. Czikora Á, Lizanecz E, Bakó P, Rutkai I, Ruzsnavszky F, et al. (2012) Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1. British Journal of Pharmacology 165: 1801-1812.
30. Pinter E, Szolcsanyi J (1995) Plasma extravasation in the skin and pelvic organs evoked by antidromic stimulation of the lumbosacral dorsal roots of the rat. Neuroscience 68: 603-614.
31. Szallasi Á, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacological Reviews 51: 159-212.
32. Caterina MJ, Leffler A, Malmberg A, Martin W, Trafton J, et al. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313.
33. Czikora Á, Lizanecz E, Boczán J, Daragó A, Papp Z, et al. (2012) Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation. Life Sciences 90: 407-415.
34. Khairatkar-Joshi N, Szallasi Á (2009) TRPV1 antagonists: the challenges for therapeutic targeting. Trends in Molecular Medicine 15: 14-22.
35. Kissin I, Szallasi A (2011) Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem 11: 2159-2170.
36. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, et al. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 97: 3655-3660.
37. Jancso G, Hokfelt T, Lundberg JM, Kiraly E, Halasz N, et al. (1981) Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J Neurocytol 10: 963-980.
38. Nagy JI, Vincent SR, Staines WA, Fibiger HC, Reisine TD, et al. (1980) Neurotoxic action of capsaicin on spinal substance P neurons. Brain Res 186: 435-444.
39. Helyes Z, Pozsgai G, Börzsei R, Németh J, Bagoly T, et al. (2007) Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat. Peptides 28: 1847-1855.
40. Helyes Z, Thán M, Oroszi G, Pintér E, Németh J, et al. (2000) Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neuroscience Letters 278: 185-188.
41. Hong S, Wiley JW (2005) Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. The Journal of Biological Chemistry 280: 618-627.
42. Facer P, Casula MA, Smith GD, Benham CD, Chessell IP, et al. (2007) Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurology 7: 11.